EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Decline in Complications and Mortality in Chronic Liver Disease and Cirrhosis: A Population‐Based Cohort Study From Northeastern Italy

Francesco Paolo Russo iD, Alberto Zanetto iD, Laura Salmaso, Claudio Barbiellini Amidei, Sara Battistella, Salvatore Piano iD, Paolo Angeli, Patrizia Burra iD, Mario Saia iD, Ugo Fedeli

United European Gastroenterology Journal · 2025

DOI: 10.1002/ueg2.70085 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Francesco Paolo Russo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, Padova, Italy. Hauptthemen laut MEDLINE: Liver Cirrhosis, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current trends in complications and mortality among individuals with chronic liver disease and cirrhosis are largely unknown.

Objective

To explore changes in mortality trends among patients with cirrhosis and chronic liver disease based on etiology in the Veneto Region (Italy), to differentiate mortality between liver‐related and non‐liver‐related causes before and during the COVID‐19 pandemic, and to determine trends in the development of cirrhosis complications.

Methods

Three subsequent population‐based cohorts of individuals with chronic liver disease/cirrhosis were identified in Veneto (North‐eastern Italy, 4.9 million residents): the first enrolled before introduction of direct‐acting antivirals (DAA); the second corresponding to full availability of DAA treatment; and the last enrolled at the beginning of the pandemic. Risks of liver decompensation and death—liver and non‐liver related—were recorded for each cohort during a 3‐year follow‐up. Changes in the risk of death across cohorts were measured by risk ratios (RR) obtained through Poisson regression models with robust error variance.

Results

Across the cohorts spanning over 10 years, we found that the number of individuals with CLD and cirrhosis remained stable at about 40,000 and 10,000, respectively. The 3‐year risk of ascites, hepatic encephalopathy, and hepatocellular carcinoma decreased across the study period, largely due to individuals with HCV‐related liver disease. The overall 3‐year mortality risk declined by 14% (liver cirrhosis, subjects enrolled in 2020 vs. 2013: RR = 0.86, 95% CI 0.83–0.89), especially among those with viral etiology. In contrast, mortality due to alcohol‐related chronic liver disease/cirrhosis was stable or increasing during the COVID‐19 pandemic, especially for non‐liver causes of death.

Conclusions

Despite increased awareness and proactive enrollment into patient care, chronic liver disease and cirrhosis remain significant health‐challenges. The reduction in HCV‐related mortality underscores the impact of antiviral treatments, while the persistently high mortality risk of alcohol‐related disease highlights the need for targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisCOVID-19HumansItalyFemaleMaleMiddle AgedAgedCohort StudiesAdultSARS-CoV-2Hepatitis C, ChronicLiver NeoplasmsLiver DiseasesChronic Disease

Stichwörter der Autor:innen

COVID‐19alcoholchronic liver diseasecirrhosisdecompensationdirect‐acting antiviralshepatitisliver‐related eventmortalityoutcome

Autor:innen und Institutionen

  • Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, Padova, Italy.
  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Clinical Governance, Azienda Zero, Padova, Italy.
  • Epidemiological Department, Azienda Zero, Padova, Italy.
  • Internal Medicine, Azienda Ospedale-Università di Padova, Padova, Italy.
  • Department of Medicine, University of Padova, Padova, Italy.

ORCID-Profile: Francesco Paolo Russo, Alberto Zanetto, Salvatore Piano, Patrizia Burra, Mario Saia

Zitieren

APA

Russo, F. P., Zanetto, A., Salmaso, L., Barbiellini Amidei, C., Battistella, S., Piano, S., Angeli, P., Burra, P., Saia, M., & Fedeli, U. (2025). Decline in Complications and Mortality in Chronic Liver Disease and Cirrhosis: A Population‐Based Cohort Study From Northeastern Italy. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70085

Vancouver

Russo FP, Zanetto A, Salmaso L, Barbiellini Amidei C, Battistella S, Piano S, et al. Decline in Complications and Mortality in Chronic Liver Disease and Cirrhosis: A Population‐Based Cohort Study From Northeastern Italy. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70085

BibTeX
@article{Russo2025,
  author = {Russo, Francesco Paolo and Zanetto, Alberto and Salmaso, Laura and Barbiellini Amidei, Claudio and Battistella, Sara and Piano, Salvatore and Angeli, Paolo and Burra, Patrizia and Saia, Mario and Fedeli, Ugo},
  title = {Decline in Complications and Mortality in Chronic Liver Disease and Cirrhosis: A Population‐Based Cohort Study From Northeastern Italy},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  doi = {10.1002/ueg2.70085}
}
Kostenlos starten →